Wealthquest Corp Invests $1.31 Million in Amedisys, Inc. (NASDAQ:AMED)

Wealthquest Corp purchased a new position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 13,516 shares of the health services provider's stock, valued at approximately $1,310,000.

A number of other large investors have also recently made changes to their positions in AMED. FNY Investment Advisers LLC lifted its holdings in Amedisys by 6,942.3% during the 1st quarter. FNY Investment Advisers LLC now owns 5,000 shares of the health services provider's stock valued at $463,000 after buying an additional 4,929 shares in the last quarter. Sagespring Wealth Partners LLC lifted its holdings in Amedisys by 12.3% during the 1st quarter. Sagespring Wealth Partners LLC now owns 3,237 shares of the health services provider's stock valued at $300,000 after buying an additional 354 shares in the last quarter. Exchange Traded Concepts LLC lifted its holdings in Amedisys by 11.5% during the 1st quarter. Exchange Traded Concepts LLC now owns 8,590 shares of the health services provider's stock valued at $796,000 after buying an additional 887 shares in the last quarter. Fifth Third Bancorp lifted its holdings in Amedisys by 68.1% during the 1st quarter. Fifth Third Bancorp now owns 348 shares of the health services provider's stock valued at $32,000 after buying an additional 141 shares in the last quarter. Finally, Bridge City Capital LLC lifted its holdings in Amedisys by 1.2% during the 1st quarter. Bridge City Capital LLC now owns 34,947 shares of the health services provider's stock valued at $3,237,000 after buying an additional 417 shares in the last quarter. 94.36% of the stock is owned by hedge funds and other institutional investors.

Amedisys Stock Down 0.1%

Shares of NASDAQ:AMED traded down $0.05 during trading hours on Thursday, hitting $98.03. The company's stock had a trading volume of 391,201 shares, compared to its average volume of 420,309. Amedisys, Inc. has a 52 week low of $82.15 and a 52 week high of $98.95. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.29 and a quick ratio of 1.29. The company has a market capitalization of $3.22 billion, a price-to-earnings ratio of 36.17, a P/E/G ratio of 1.33 and a beta of 0.94. The firm's fifty day moving average price is $95.03 and its 200 day moving average price is $92.43.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The health services provider reported $1.25 EPS for the quarter, beating the consensus estimate of $1.13 by $0.12. Amedisys had a net margin of 3.79% and a return on equity of 12.52%. The business had revenue of $594.78 million during the quarter, compared to analyst estimates of $597.43 million. During the same quarter in the previous year, the business posted $1.03 EPS. The company's quarterly revenue was up 4.1% compared to the same quarter last year. As a group, research analysts expect that Amedisys, Inc. will post 4.4 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Wall Street Zen lowered shares of Amedisys from a "strong-buy" rating to a "buy" rating in a report on Saturday, May 24th. Stephens reiterated an "equal weight" rating and set a $101.00 price objective on shares of Amedisys in a report on Tuesday, March 4th. Finally, Royal Bank Of Canada reiterated an "outperform" rating and set a $100.00 price objective on shares of Amedisys in a report on Wednesday, April 16th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, Amedisys currently has an average rating of "Hold" and a consensus price target of $100.75.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.